Top

Supportive Care in Cancer

Published in:

01-09-2014 | Original Article

Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer

Authors: Teresa Brown, Lynda Ross, Lee Jones, Brett Hughes, Merrilyn Banks

Published in: Supportive Care in Cancer | Issue 9/2014

Abstract

Purpose

Head and neck cancer patients have a high risk of malnutrition and swallowing dysfunction. This study reports on adherence and nutrition outcomes with the use of local evidence-based guidelines for the nutrition management of patients with head and neck cancer, including placement of proactive gastrostomy tubes for high risk patients.

Methods

This study is a prospective observational audit in patients treated for head and neck cancer at a tertiary hospital from 2007 to 2008 (n = 539). Nutrition outcomes (weight, nutritional status and type of nutrition support) were compared for each nutrition risk category. Primary outcome was 10 % or more weight loss at 3 months post-treatment (n = 219).

Results

Overall adherence to the guideline tube feeding recommendations was 81 %. High risk patients had mean weight loss of 6 % on completion of treatment and 9 % at 3 months post-treatment, despite the majority having a proactive gastrostomy tube. Medium and low risk patients also lost weight over this time. Univariate analysis found that non-adherence to the guidelines was associated with weight loss at 3 months (p = 0.013). Multivariate analysis found overweight patients had 1.82 greater odds, and obese patients had 3.49 greater odds of losing weight (p = 0.021). Patients with significant weight loss at diagnosis had decreased odds of losing weight later (p = 0.011).

Conclusion

Clinically significant weight loss was still prevalent in this population despite proactive interventions. Predictors of weight loss support the evidence-based guidelines’ risk categories, and adherence was important to improve outcomes. Further research is required to determine the impact of significant weight loss in patients with high body mass index (BMI).

Nugent B, Lewis S, O’Sullivan JM (2010) Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database of Systematic Reviews (Online): CD007904

Scolapio JS, Spangler PR, Romano MM, McLaughlin MP, Salassa JR (2001) Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile? J Clin Gastroenterol 33(3):215–217PubMedCrossRef

Beaver ME, Matheny KE, Roberts DB, Myers JN (2001) Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 125(6):645–648PubMedCrossRef

Tyldesley S, Sheehan F, Munk P, Tsang V, Skarsgard D, Bowman CA, Hobenshield SE (1996) The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys 36(5):1205–1209PubMedCrossRef

Senft M, Fietkau R, Iro H, Sailer D, Sauer R (1993) The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care Cancer 1(5):272–275PubMedCrossRef

Fietkau R, Iro H, Sailer D, Sauer R (1991) Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res 121:269–282PubMedCrossRef

Salas S, Baumstarck-Barrau K, Alfonsi M, Digue L, Bagarry D, Feham N, Bensadoun RJ, Pignon T, Loundon A, Deville JL, Zanaret M, Favre R, Duffaud F, Auquier P (2009) Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: prospective randomized trial. Radiother Oncol 93(3):503–509PubMedCrossRef

Lee JH, Machtay M, Unger LD, Weinstein GS, Weber RS, Chalian AA, Rosenthal DI (1998) Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124(8):871–875PubMedCrossRef

Piquet MA, Ozsahin M, Larpin I, Zouhair A, Coti P, Monney M, Monnier P, Mirimanoff RO, Roulet M (2002) Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer 10(6):502–504PubMedCrossRef

10.

Hughes BG, Jain VK, Brown T, Spurgin AL, Hartnett G, Keller J, Tripcony L, Appleyard M, Hodge R (2013) Decreased hospital stay and significant cost savings after routine use of prophylactic gastrostomy for high-risk patients with head and neck cancer receiving chemoradiotherapy at a tertiary cancer institution. Head Neck 35(3):436–442PubMedCrossRef

11.

Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL, Birchall MA (2009) Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol 34(2):103–112PubMedCrossRef

12.

Corry J, Poon W, McPhee N, Milner AD, Cruickshank D, Porceddu SV, Rischin D, Peters LJ (2008) Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo) radiation. J Med Imaging Radiat Oncol 52(5):503–510PubMedCrossRef

13.

Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P (2001) Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 91(9):1785–1790PubMedCrossRef

14.

Shiley SG, Hargunani CA, Skoner JM, Holland JM, Wax MK (2006) Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134(3):455–459PubMedCrossRef

15.

Gillespie MB, Brodsky MB, Day TA, Sharma AK, Lee FS, Martin-Harris B (2005) Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 131(7):615–619PubMedCrossRef

16.

Chang YC, Chen SY, Lui LT, Wang TG, Wang TC, Hsiao TY, Li YW, Lien IN (2003) Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study. Dysphagia 18(2):135–143PubMedCrossRef

17.

Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA (2003) Swallowing dysfunction—preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57(5):1219–1230PubMedCrossRef

18.

Pauloski BR, Rademaker AW, Logemann JA, Stein D, Beery Q, Newman L, Hanchett C, Tusant S, MacCracken E (2000) Pretreatment swallowing function in patients with head and neck cancer. Head Neck 22(5):474–482PubMedCrossRef

19.

Colangelo LA, Logemann JA, Rademaker AW (2000) Tumor size and pretreatment speech and swallowing in patients with resectable tumors. Otolaryngol Head Neck Surg 122(5):653–661PubMed

20.

Gardine RL, Kokal WA, Beatty JD, Riihimaki DU, Wagman LD, Terz JJ (1988) Predicting the need for prolonged enteral supplementation in the patient with head and neck cancer. Am J Surg 156(1):63–65PubMedCrossRef

21.

Moor JW, Patterson J, Kelly C, Paleri V (2010) Prophylactic gastrostomy before chemoradiation in advanced head and neck cancer: a multiprofessional web-based survey to identify current practice and to analyse decision making. Clin Oncol 22(3):192–198CrossRef

22.

Brown TE, Spurgin AL, Ross L, Tripcony L, Keller J, Hughes BG, Hodge R, Walker Q, Banks M, Kenny LM, Crombie J (2012) Validated swallowing and nutrition guidelines for patients with head and neck cancer: identification of high-risk patients for proactive gastrostomy. Head Neck 35(10):1385–1391. doi:10.1002/hed.23146. Epub 2012 Sep 13PubMed

23.

Ferguson ML, Bauer J, Gallagher B, Capra S, Christie DR, Mason BR (1999) Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol 43(3):325–327PubMedCrossRef

24.

Ottery F (2005) Patient-generated subjective global assessment. In: The clinical guide to oncology nutrition. American Dietetic Association, Chicago

25.

Isenring E, Zabel R, Bannister M, Brown T, Findlay M, Kiss N, Loeliger J, Johnstone C, Camilleri B, Davidson W, Hill J, Bauer J (2013) Updated evidence-based practice guidelines for the nutritional management of patients receiving radiation therapy and/or chemotherapy. Nutr Diet. doi:10.1111/1747-0080.12013

26.

Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME (2005) Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 27(8):659–668PubMedCrossRef

27.

Isenring EA, Capra S, Bauer JD (2004) Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91(3):447–452PubMedCentralPubMedCrossRef

28.

Jager-Wittenaar H, Dijkstra PU, Vissink A, Langendijk JA, van der Laan BF, Pruim J, Roodenburg JL (2011) Changes in nutritional status and dietary intake during and after head and neck cancer treatment. Head Neck 33(6):863–870PubMedCrossRef

29.

Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437PubMedCrossRef

30.

Ferguson M, Capra S, Bauer J, Banks M (1999) Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition 15(6):458–464PubMedCrossRef

31.

Garg S, Yoo J, Winquist E (2010) Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. Support Care Cancer 18(6):667–677PubMedCrossRef

32.

Nugent B, Parker MJ, McIntyre IA (2010) Nasogastric tube feeding and percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. J Hum Nutr Diet 23(3):277–284PubMedCrossRef

33.

Munshi A, Pandey MB, Durga T, Pandey KC, Bahadur S, Mohanti BK (2003) Weight loss during radiotherapy for head and neck malignancies: what factors impact it? Nutr Cancer 47(2):136–140PubMedCrossRef

34.

Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, Nabid A, Brochet F, Tetu B, Meyer F (2010) Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 116(9):2275–2283PubMed

35.

Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di Palma A, Pavese I, Satta F, Tosti M, Palladino A, Coiro G, Di Palma M (2008) Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 30(4):503–508PubMedCrossRef

36.

van den Berg MG, Rasmussen-Conrad EL, Gwasara GM, Krabbe PF, Naber AH, Merkx MA (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25(5):765–772PubMedCrossRef

37.

van den Berg MG, Rasmussen-Conrad EL, van Nispen L, van Binsbergen JJ, Merkx MA (2008) A prospective study on malnutrition and quality of life in patients with head and neck cancer. Oral Oncol 44(9):830–837PubMedCrossRef

38.

Langius JA, van Dijk AM, Doornaert P, Kruizenga HM, Langendijk JA, Leemans CR, Weijs PJ, Verdonck-de Leeuw IM (2013) More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer 65(1):76–83PubMedCrossRef

39.

World Cancer Research Fund and American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research (AICR), Washington, DC

Title: Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer
Authors: Teresa Brown
Lynda Ross
Lee Jones
Brett Hughes
Merrilyn Banks
Publication date: 01-09-2014
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2180-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2014

The impact of bone mineral density testing, fracture assessment, and osteoporosis education in men treated by androgen deprivation for prostate cancer: a pilot study

Exploring the role of the partner in couples’ sexual recovery after surgery for prostate cancer

Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice

Psychosocial factors predicting survival after allogeneic stem cell transplant

Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’ use of the information: a randomized controlled clinical trial

Health media use among childhood and young adult cancer survivors who smoke

Keynote webinar | Spotlight on antibody–drug conjugates in cancer